Macrophagic myofasciitis: An emerging entity

Lancet

Volumn 352, Issue 9125, 1998, Pages 347-352

  Gherardi, R K ^a   Coquet, M ^b   Cherin P ^c   Authier, F J ^a   Laforet P ^c   Belec L ^d   Figarella Branger, D ^e   Mussini, J M ^f   Pellissier, J F ^e   Fardeau, M ^c  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d HÔPITAL BROUSSAIS   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD8 ANTIGEN; CREATINE KINASE; STEROID;

ADULT; AGED; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL ARTICLE; ELECTROMYOGRAM; EPITHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; FASCIITIS; FEMALE; FEVER; FRANCE; GIANT CELL; HUMAN; INFLAMMATION; INTESTINE LIPODYSTROPHY; MACROPHAGE; MALACOPLAKIA; MALE; MITOSIS; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; MYCOBACTERIUM INTRACELLULARE AVIUM; MYOPATHY; PANNICULITIS; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; SUBCUTANEOUS TISSUE; T LYMPHOCYTE;

EID: 0032145490     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)02326-5     Document Type: Article

References (29)

1. 1 Schwartz DA. Emerging and reemerging infections: progress and challenges in the subspecialty of infectious disease pathology. Arch Pathol Lab Med 1997; 121: 776-84.
2. 2 Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991; 325: 1487-98.
3. 3 Banker BQ. Other inflammatory myopathies. In: Engel AG, Franzini-Armstrong, eds. Myology, 2nd edn, vol 2. New York: McGraw-Hill, 1993: 1461-86.
4. 4 Alonzo-Ruiz A, Zea-Mendoza AC, Salazar-Vallinas JM, Rocamora-Ripoll A, Beltran-Guttierrez D. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum 1986; 15: 200-12.
5. 5 Kaufman LD, Seidman RJ, Gruber BL. L-tryptophan-associated eosinophilic perimyositis, neuritis and fasciitis: a clinicopathogic and laboratory study of 25 patients. Medicine 1990; 69: 187-99.
6. 6 Mayeno AN, Benson LM, Naylor S, Colberg-Beers M, Puchalski JT, Gleich GJ. Biotransformation of 3-(phenylamino) 1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome. Chem Res Toxicol 1995; 8: 911-16.
7. 7 Gherardi R. Skeletal muscle involvement in HIV-infected patients. Neuropathol Appl Neurobiol 1994; 20: 232-37.
8. 8 Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990; 322: 1098-05.
9. 9 Mhiri C, Baudrimont M, Bonne G, et al. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 1991; 29: 606-14.
10. 10 Naschitz JE, Boss JH, Misselevitch I, Yeshurun D, Rosner I. The fasciitis-panniculitis syndromes: clinical and pathologic features. Medicine 1996; 75: 6-16.
11. 11 Snow JL, Daniel Su WP. Histiocytic disorders. J Am Acad Dermatol 1995; 33: 111-16.
12. 12 Friedlander JS, Weatherall DJ, Ledingham JGG. A chronic granulomatous syndrome of unknown origin. Medicine 1990; 69: 325-31.
13. 13 Cline MJ. Histiocytes and histiocytosis. Blood 1994; 84: 2840-53.
14. 14 Zellger BWH, Sidoroff A, Orchard G, Cerio R. Non-Langerhans cells histiocytosis: a new unifying concept. Am J Dermatopathol 1996; 18: 490-504.
15. 15 Marth T, Neurath M, Cuccherini BA, Strober W. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology 1997; 113: 442-48.
16. 16 Gao IK, Goronzy JJ, Weyand CM. Ten year follow-up of a patient with multicentric reticulohistiocytosis associated with myopathy. Scand J Rheumatol 1990; 19: 437-41.
17. 17 Lack EE. Malakoplakia. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, eds. Pathology of infectious diseases, vol 2. Stamford, USA: Appleton and Lange, 1997: 1647-54.
18. 18 Dobbins WO III. Whipple's disease. In: Connor DH, Chandler FW, Schwarte DA, Manz HJ, Lack EE, eds. Pathology of infectious diseases, vol 1. Stamford, USA: Appleton and Lange, 1997: 897-903.
19. 19 Miranda D, Vuletin JC, Kauffman SL. Disseminated histiocytosis and intestinal malakoplakia: occurrence due to Mycobacterium intracellulare infection. Arch Pathol Lab Med 1979; 103: 302-05.
20. 20 Gillin JS, Urmacher C, West R, Shike M. Disseminated Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease. Gastroenterology 1983; 85: 1187-91.
21. 21 Swash M, Schwartz MS, Vandenburg MJ, Pollock DJ. Myopathy in Whipple's disease. Gut 1977; 18: 800.
22. 22 Banker BQ, Engel AG. Basic reactions of muscle. In: Engel AG, Franzini-Armstrong, eds. Myology, 2nd edn, vol 1. New York: McGraw-Hill, 1993: 832-88.
23. 23 Vital Durand D, Lecomte C, Cathébras P, Rousset H, Godeau P, SNFMI research group on Whipple's disease. Whipple disease: clinical review of 52 cases. Medicine 1997; 76: 170-84.
24. 24 Wrzolek MA, Sher JH, Kozlovski PB, Rao C. Skeletal muscle pathology in AIDS: an autopsy study. Muscle Nerve 1990; 13: 508-15.
25. 25 Watt B. Lesser known mycobacteria. J Clin Pathol 1995; 48: 701-05.
26. 26 Michelini-Norris MB, Blanchard DK, Pearson CA, Djeu JY. Differential release of interleukin (IL)-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avitulent isogenic variant of Mycobacterium avium-intracellulare complex. J Infect Dis 1992; 165: 702-09.
27. 27 Sathe SS, Sarai A, Tsigler D, Nedunchezian D. Pentoxifylline aggravates impairment in tumor necrosis factor-alpha secretion and increases mycobacterial load in macrophages from AIDS patients with disseminated Mycobacterioum avium-intracellulare complex infection. J Infect Dis 1994; 170: 484-87.
28. 28 Frucht DM, Holland SM. Defective monocyte costimulation for IFN-γ production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J Immunol 1996; 157: 41-16.
29. 29 Sperber K, Quraishi H, Kalb TH, Panja A, Stecher V, Mayer L. Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1 alpha) and IL-6 in human monocytes and T-cells. J Rheumatol 1993; 2): 803-08.